Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q2)Mar 31, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
---|---|---|---|---|---|
Assets | |||||
Current assets | |||||
Cash, cash equivalents and short term investments | 6.35%2.05B | --2.05B | --1.72B | 16.45%1.92B | --1.65B |
-Cash and cash equivalents | 6.35%2.05B | --2.05B | --1.72B | 16.45%1.92B | --1.65B |
Receivables | 64.31%195.16M | --195.16M | --163.31M | 71.71%118.77M | --69.17M |
-Accounts receivable | 64.31%195.16M | --195.16M | --163.31M | 71.71%118.77M | --69.17M |
-Gross accounts receivable | 64.31%195.16M | --195.16M | --163.31M | 71.71%118.77M | --69.17M |
Inventory | -61.49%2.02M | --2.02M | --3.93M | 308.07%5.26M | --1.29M |
Prepaid assets | 10.83%38.88M | --38.88M | --38.46M | 4.48%35.08M | --33.58M |
Other current assets | 97.26%2.09M | --2.09M | --2.72M | -35.03%1.06M | --1.63M |
Total current assets | 9.61%2.28B | --2.28B | --1.93B | 18.57%2.08B | --1.76B |
Non current assets | |||||
Net PPE | 37.51%21.02M | --21.02M | --21.06M | -8.52%15.28M | --16.71M |
-Gross PP&E | 37.51%21.02M | --21.02M | --21.06M | -8.52%15.28M | --16.71M |
Total investment | 0.00%10K | --10K | --10K | 0.00%10K | --10K |
-Other investment | 0.00%10K | --10K | --10K | 0.00%10K | --10K |
Goodwill and other intangible assets | --13.57M | --13.57M | ---- | --0 | ---- |
-Other intangible assets | --13.57M | --13.57M | ---- | ---- | ---- |
Deferred tax assets-non current | --97.57M | --97.57M | ---- | --0 | ---- |
Other non current assets | --2K | --2K | ---- | ---- | ---- |
Total non current assets | 764.31%132.17M | --132.17M | --21.07M | -8.51%15.29M | --16.72M |
Total assets | 15.11%2.42B | --2.42B | --1.95B | 18.31%2.1B | --1.77B |
Liabilities | |||||
Current liabilities | |||||
Financial liabilities | 208.57%216M | --216M | --144M | 75.00%70M | --40M |
-Current debt and capital lease obligation | 208.57%216M | --216M | --144M | 75.00%70M | --40M |
-Including:Current debt | 208.57%216M | --216M | --144M | 75.00%70M | --40M |
Payables | 9.18%284.54M | --284.54M | --208.88M | 69.53%260.61M | --153.72M |
-Total tax payable | 285.93%111.49M | --111.49M | --52.46M | 1,161.48%28.89M | --2.29M |
-Other payable | -25.32%173.06M | --173.06M | --156.42M | 53.02%231.72M | --151.43M |
Accrued and deferred income | 16.75%589.22M | --589.22M | --400.41M | 33.90%504.68M | --376.9M |
Other current liabilities | -33.32%11.67M | --11.67M | --22.09M | 148.68%17.51M | --7.04M |
Current liabilities | 29.16%1.1B | --1.1B | --775.38M | 47.63%852.8M | --577.67M |
Non current liabilities | |||||
Non current financial liabilities | -38.52%664M | --664M | --796M | 13.68%1.08B | --950M |
-Long term debt and capital lease obligation | -38.52%664M | --664M | --796M | 13.68%1.08B | --950M |
-Including:Long term debt | -38.52%664M | --664M | --796M | 13.68%1.08B | --950M |
Other non current liabilities | ---- | ---- | ---- | --1K | ---- |
Total non current liabilities | -38.52%664M | --664M | --796M | 13.68%1.08B | --950M |
Total liabilities | -8.66%1.77B | --1.77B | --1.57B | 26.52%1.93B | --1.53B |
Shareholders'equity | |||||
Share capital | 0.00%100M | --100M | --100M | 0.00%100M | --100M |
-common stock | 0.00%100M | --100M | --100M | 0.00%100M | --100M |
Additional paid-in capital | -51.00%365.49M | --365.49M | --365.49M | -21.03%745.89M | --944.51M |
Retained earnings | 127.10%184.39M | --184.39M | ---82.7M | 14.81%-680.39M | ---798.65M |
Total stockholders'equity | 292.68%649.88M | --649.88M | --382.8M | -32.69%165.5M | --245.86M |
Total equity | 292.68%649.88M | --649.88M | --382.8M | -32.69%165.5M | --245.86M |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |